The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients
Open accessAbstract
Although treating anemia of chronic kidney disease by erythropoiesis-stimulating agents (ESA) may improve survival, most studies have examined associations between baseline hemoglobin values and survival and ignored variations in clinical and laboratory measures over time. It is not clear whether longitudinal changes in hemoglobin or administered ESA have meaningful associations with survival after adjustment for time-varying confounders. With the use of time-dependent Cox regression models, longitudinal associations were examined between survival and quarterly (13-wk averaged) hemoglobin values and administered ESA dose in a 2-yr (July 2001 to June 2003) cohort of 58,058 maintenance hemodialysis patients from a large dialysis organization (DaVita) in the United States. After time-dependent and multivariate adjustment for case mix, quarterly varying administered intravenous iron and ESA doses, iron markers, and nutritional status, hemoglobin levels between 12 and 13 g/dl were associated with the greatest survival. Among prevalent patients, the lower range of the recommended Kidney Disease Quality Outcomes Initiative hemoglobin target (11 to 11.5 g/dl) was associated with a higher death risk compared with the 11.5- to 12-g/dl range. A decrease or increase in hemoglobin over time was associated with higher or lower death risk, respectively, independent of baseline hemoglobin. Administration of any dose of ESA was associated with better survival, whereas among those who received ESA, requiring higher doses were surrogates of higher death risk. In this observational study, greater survival was associated with a baseline hemoglobin between 12 and 13 g/dl, treatment with ESA, and rising hemoglobin. Falling hemoglobin and requiring higher ESA doses were associated with decreased survival. Randomized clinical trials are required to examine these associations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Locatelli, F. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh1032 · Cited by 785
Activated Injectable Vitamin D and Hemodialysis Survival: A Historical Cohort Study
Teng, M., Wolf, M., Ofsthun, M. N., Lazarus, J. M., Hernán, M. A., Camargo, C. A., & Thadhani, R. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070573 · Cited by 782
The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease
Foley, R. N., Parfrey, P. S., Harnett, J. D., Kent, G. M., Murray, D. C., & Barre, P. E. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90130-4 · Cited by 769
Parfrey, P. S., Foley, R. N., Wittreich, B. H., Sullivan, D. J., Zagari, M. J., & Frei, D. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004121039 · Cited by 373
Kalantar-Zadeh, K., Kilpatrick, R. D., Kuwae, N., McAllister, C. J., Alcorn, H., Kopple, J. D., & Greenland, S. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh941 · Cited by 360
Self-citationGunnell, J., Yeun, J. Y., Depner, T. A., & Kaysen, G. A. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70259-3 · Cited by 305
Kalantar-Zadeh, K., McAllister, C. J., Lehn, R. S., Lee, G. H., Nissenson, A. R., & Kopple, J. D. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00915-6 · Cited by 304
Self-citationKalantar-Zadeh, K., Kopple, J. D., Kilpatrick, R. D., McAllister, C. J., Shinaberger, C. S., Gjertson, D. W., & Greenland, S. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.05.020 · Cited by 290
Self-citationTime-Dependent Associations between Iron and Mortality in Hemodialysis Patients
Kalantar-Zadeh, K., Regidor, D. L., McAllister, C. J., Michael, B., & Warnock, D. G. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005040423 · Cited by 285
Self-citationEpoetin requirements predict mortality in hemodialysis patients
Zhang, Y., Thamer, M., Stefanik, K., Kaufman, J., & Cotter, D. J. (2004) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(04)01086-8 · Cited by 271
Cited by
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
Drüeke, T. B., Locatelli, F., Clyne, N., Eckardt, K.-U., Macdougall, I. C., Tsakiris, D., Burger, H.-U., & Scherhag, A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062276 · Cited by 2,104
Kalantar-Zadeh, K., Kuwae, N., Regidor, D. L., Kovesdy, C. P., Kilpatrick, R. D., Shinaberger, C. S., McAllister, C. J., Budoff, M. J., Salusky, I. B., & Kopple, J. D. (2006) · Kidney International · doi:10.1038/sj.ki.5001514 · Cited by 905
Self-citation(2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.06.008 · Cited by 727
Jones, M., Ibels, L., Schenkel, B., & Zagari, M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00450.x · Cited by 665
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis
Chen, N., Hao, C., Peng, X., Lin, H., Yin, A., Hao, L., Tao, Y., Liang, X., Liu, Z., Xing, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1813599 · Cited by 582
Metadata
- Authors
- Regidor, D. L., Kopple, J. D., Kovesdy, C. P., Kilpatrick, R. D., McAllister, C. J., Aronovitz, J., Greenland, S., & Kalantar-Zadeh, K.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2006-04
- Volume
- 17
- Issue
- 4
- Pages
- 1181-1191
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2105642896
- Cited by
- 408
- References
- 33
- FWCI
- 21.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients. https://app.cochat.ai/papers/10.1681/asn.2005090997
- The paper
- Regidor, D. L., Kopple, J. D., Kovesdy, C. P., Kilpatrick, R. D., McAllister, C. J., Aronovitz, J., Greenland, S., & Kalantar-Zadeh, K. (2006). Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2005090997
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.